Amid a tough year for biotech, these Mass. companies just raised $1B
Veterans of the biotech business sometimes talk about surviving various “winters” for their industry — periods when funding drops and companies cut jobs or shut down entirely. They’re living through a bitterly cold stretch now, with recent layoffs at companies such as Takeda Pharmaceuticals, BioNTech, and Arena BioWorks, all of which have Massachusetts sites. But there […]
Exclusive: Cellens raises $6.5M to ad-vance physics-based test for bladder cancer
Boston-based company Cellens secured $6.5 million to develop its platform that detects bladder cancer through an approach that combines physics and AI, End-points News learned exclusively. Its technology is a departure from the norm in cancer diagnostics, in which scientists largely rely on molecular markers inside the cell. Cellens uses atomic force microscopy, which “feels” […]
Turning physics into a diagnostic signal for bladder cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures. Bladder cancer remains one of the most expensive cancers to monitor, not because treatment is uniquely complex, but because recurrence is common and surveillance is invasive and costly. Cystoscopy, the gold standard for detecting bladder tumors, lets clinicians evaluate the number, size, and location […]
Cellens Raises $6.5M to Advance Its AI-Driven Mechanobiology Platform for Non-Invasive Bladder Cancer Diagnostics
BOSTON, MA, UNITED STATES, December 23, 2025 /EINPresswire.com/ — Cellens, Inc., a cancer diagnostics company pioneering a new mechanobiology and AI-driven platform, BioFeel™, for non-invasive cancer detection, has raised a $6.5M Series Seed round. The financing follows compelling early clinical data generated with leading urologists at Harvard’s Brigham and Women’s Hospital, showing that the company’s […]
Detection of Human Bladder Epithelial Cancerous Cells with Atomic Force Microscopy and Machine Learning
Mikhail Petrov 1, Nadezhda Makarova 1, Amir Monemian 2, Jean Pham 2, Małgorzata Lekka 3, Igor Sokolov 1 4 Affiliations Expand Abstract The development of noninvasive methods for bladder cancer identification remains a critical clinical need. Recent studies have shown that atomic force microscopy (AFM), combined with pattern recognition machine learning, can detect bladder cancer by analyzing cells extracted from urine. However, these promising findings were limited by […]
Springboard Enterprises Announces Inaugural 2024 Healthcare and Technology Accelerator Program Cohort
The 2024 Accelerator Program Features Nine Women Driving Transformational Health Solutions WASHINGTON, DC, UNITED STATES, September 11, 2024 /EINPresswire.com/ — Springboard Enterprises, a leader in fostering women-led innovation, is proud to announce its 2024 Healthcare and Technology Cohort. The nine selected companies, led by innovative female founders, are addressing key areas in healthcare such as cancer […]
Cellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection
BOSTON–(BUSINESS WIRE)–Cellens, Inc., an early-stage cancer diagnostic company pioneering in applying mechanobiology and machine learning analysis today announced that it is collaborating with Bruker BioAFM, a business unit of Bruker(Nasdaq: BRKR), to develop the world’s first clinical diagnostic tests that leverage multi-parametric, single-cell biophysical markers and machine learning. Based on cellular biophysical markers attained using Bruker’s advanced atomic […]
LabCentral, a crucial incubator for local drug discovery, is slated to grow amid industry slowdown
For the past year, Jean Pham and a pair of employees at her three-year-old company, Cellens, shared high-tech research instruments with scores of other scientists under a LabCentral program aiding startups owned by women and people of color.MATTHEW J. LEE/GLOBE STAFF With funding constrained, some biotech startups are staying longer in shared space CAMBRIDGE — […]
CELLENS IS ON SOSV HUMAN HEALTH 100 LIST
Welcome to the second annual SOSV Human Health 100. The list captures SOSV’s 100 most exciting companies in human health as of April 2023. SOSV’s core mission, which we pursue through our IndieBio, HAX, and Orbit startup development programs, is to fund and foster startups that will improve human and planetary health. In addition to the Human Health 100, […]
CELLENS WON GOLDEN TICKET IGNITE AWARD
CAMBRIDGE, Mass., Oct. 5, 2022 /PRNewswire/ — LabCentral Ignite, with support from key sponsors Pfizer, Bristol Myers Squibb and Mission BioCapital, today announced the winners of its second annual Golden Ticket contest: Cellens, Guardian Bio, QurCan Therapeutics and Spheric Bio. The winners were unveiled at LabCentral Ignite’s bioDiversity Summit & Awards, a new annual event that brings the entire biotech ecosystem together to discuss […]
